CSS
BIO icon

Cubist Systematic Strategies’s Bio-Rad Laboratories Class A BIO Stock Holding History

Cubist Systematic Strategies’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-700
Closed -$242K – 3013
2024
Q1 		$242K Sell
700
-8,700
-93% -$2.86M ﹤0.01% 2984
2023
Q4 		$3.04M Buy
+9,400
New +$2.95M 0.02% 1190

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Cubist Systematic Strategies's BIO Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2025: 2,983 shares worth $836K. The stake represents ﹤0.01% of the portfolio and ranks #2032 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in BIO as recently as Q1 2024.

Cubist Systematic Strategies first reported a position in BIO in Q2 2015 and has held it in 35 quarters since. The position peaked at $14.1M in Q1 2022. 397 funds tracked by Wall St. Rank hold BIO as of Q3 2025.

  • Cubist Systematic Strategies held 2,983 shares of Bio-Rad Laboratories Class A worth $836K as of Q3 2025.
  • Bio-Rad Laboratories Class A was a new Cubist Systematic Strategies position in Q3 2025.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2032 holding.
  • Cubist Systematic Strategies first reported a position in Bio-Rad Laboratories Class A in Q2 2015 and has held it in 35 quarters since.
  • Cubist Systematic Strategies's Bio-Rad Laboratories Class A position peaked at $14.1M in Q1 2022.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.